U.S. stocks were mixed, with the Dow Jones index falling more than 200 points on Tuesday.
Shares of The J. M. Smucker Company (NYSE:SJM) rose sharply during Tuesday's session after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance with its midpoint above estimates.
Smucker shares surged 6.2% to $120.60 on Tuesday.
Here are some other big stocks recording gains in today's session.
- Hesai Group (NASDAQ:HSAI) shares jumped 59% to $7.55 after the company reported better-than-expected third-quarter sales results.
- Embecta Corp. (NASDAQ:EMBC) gained 30.2% to $18.76 after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates.
- LexinFintech Holdings Ltd. (NASDAQ:LX) surged 22.8% to $4.1750 after the company announced its board approved an amendment for a dividend policy to increase the payout ratio. Also, the company reported third-quarter financial results.
- Semtech Corporation (NASDAQ:SMTC) gained 20.3% to $64.32 as the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance with its midpoint above estimates.
- Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) gained 18.1% to $22.17 after the company entered into a global licensing and collaboration agreement with Sarepta Therapeutics for multiple clinical and preclinical siRNA programs.
- Neurogene Inc. (NASDAQ:NGNE) shares rose 15% to $25.65.
- SmartRent, Inc. (NYSE:SMRT) gained 13.8% to $1.8450.
- Sangamo Therapeutics, Inc. (NASDAQ:SGMO) gained 12.6% to $2.1850.
- POET Technologies Inc. (NASDAQ:POET) surged 12.2% to $4.77. POET Technologies recently announced plans to expand its capacity.
- Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares gained 9.1% to $125.10 after the company announced a global licensing and collaboration agreement with Arrowhead Pharmaceuticals for multiple clinical and preclinical siRNA programs.
- NRG Energy, Inc. (NYSE:NRG) gained 8% to $99.21 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $93 to $113.
- Exact Sciences Corporation (NASDAQ:EXAS) surged 7.8% to $59.45. The company announced it will present 10 abstracts at SABCS.
- Woodward, Inc. (NASDAQ:WWD) surged 7.4% to $192.62 after the company reported better-than-expected fourth-quarter EPS and sales.
- Rocket Lab USA, Inc. (NASDAQ:RKLB) gained 7.3% to $25.82.
- Hanesbrands Inc. (NYSE:HBI) gained 5.8% to $8.94. UBS analyst Jay Sole upgraded Hanesbrands from Neutral to Buy and raised the price target from $9 to $11.
Now Read This:
